TARS — Tarsus Pharmaceuticals, Inc. stock price, charts and financials

QT62Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
67.26
+2.47+3.81%
OverviewShort InterestFilings
TARSQT62Tarsus Pharmaceuticals, Inc.·NASDAQ
67.26+3.81%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 06, 20268-KCurrent report
Jul 13, 20268-KCurrent report
Jul 08, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 448
Page
▼
/ 18